Robust production of heavy-chain-only antibodies in mice by CRISPR/Cas mediated in situ modification of IgH locus
Authors:
Open Access
- 12 May 2026
- journal article
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 13 (11) , nwag270
Abstract
No abstract availableFunding Information
- National Key Research and Development Program of China (2021YFA0805905)
- National Key Research and Development Program of China (2022YFD1300704)
- National Key Research and Development Program of China (2023YFF1000900)
- China Agricultural University
This publication has 10 references indexed in Scilit:
- Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoireNature Communications, 2024
- Positive selection of IgG+ over IgM+ B cells in the germinal center reactionImmunity, 2021
- Genetic removal of the CH1 exon leads to the production of hypofunctional heavy chain-only IgG2a in ratsTransgenic Research, 2020
- Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesFrontiers in Immunology, 2019
- Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in MiceFrontiers in Immunology, 2018
- Ig Heavy Chain Promotes Mature B Cell Survival in the Absence of Light ChainThe Journal of Immunology, 2007
- Generation of heavy-chain-only antibodies in miceProceedings of the National Academy of Sciences, 2006
- Expression of a Dromedary Heavy Chain-Only Antibody and B Cell Development in the MouseThe Journal of Immunology, 2005
- Nanobodies as novel agents for cancer therapyExpert Opinion on Biological Therapy, 2005
- Naturally occurring antibodies devoid of light chainsNature, 1993